Details for: DOPAMINE HCL DEXTROSE INJ USP
Company: BAXTER CORPORATION
| DIN | DIN name | Active Ingredient(s) | Strength | Dosage Form | Route of Administration |
|---|---|---|---|---|---|
| 00761850 | DOPAMINE HCL 0.8MG/ML DEXTROSE 5% INJ USP | DOPAMINE HYDROCHLORIDE; DEXTROSE | 0.8 MG / ML; 50 MG / ML | SOLUTION | INTRAVENOUS |
| 00761826 | DOPAMINE HCL 1.6MG/ML DEXTROSE 5% INJ USP | DOPAMINE HYDROCHLORIDE; DEXTROSE | 1.6 MG / ML; 50 MG / ML | SOLUTION | INTRAVENOUS |
| 00761834 | DOPAMINE HCL 3.2MG/ML DEXTROSE 5% INJ USP | DOPAMINE HYDROCHLORIDE; DEXTROSE | 3.2 MG / ML; 50 MG / ML | SOLUTION | INTRAVENOUS |
Consumer Information
This information was provided by the drug’s manufacturer when this drug product was approved for sale in Canada. It is designed for consumers and care givers. It is a summary of information about the drug and will not tell you everything about the drug. Contact your doctor or pharmacist if you have any questions about the drug.
What the medication is used for
Dopamine Hydrochloride and 5% Dextrose Injection, USP may be used to increase low blood pressure in people who have:
- experienced a heart attack;
- lost blood during an accident;
- a severe infection;
- kidney failure;
- problems after surgery.
Dopamine Hydrochloride and 5% Dextrose Injection, USP may be used in people with congestive heart failure to help the heart pump better.
What it does
Dopamine Hydrochloride and 5% Dextrose Injection, USP acts to increase the blood flow to the muscles and can increase the heart's pumping efficiency. Dopamine Hydrochloride and 5% Dextrose Injection, USP also increases blood flow to the kidneys.
When it should not be used
Dopamine Hydrochloride and 5% Dextrose Injection, USP should not be given to patients with:
- allergies to dopamine hydrochloride, dextrose or any nonmedicinal ingredient in the formulation or components of the VIAFLEX Plastic container;
- are sensitive to sulfites;
- adrenal gland tumour (pheochromocytoma);
- irregular heart beat (arrhythmia).
The solution contains dextrose and should not be used in patients with known allergy to corn or corn products.
What the medicinal ingredient is
Dopamine hydrochloride
What the non-medicinal ingredients are
Dextrose, Sodium bisulfite.
What dosage form it comes in
Solution for intravenous injection 800 μg/mL, 1600 μg/mL and 3200 μg/mL
Warnings and precautions
BEFORE you are given Dopamine Hydrochloride and 5% Dextrose Injection, USP talk to your doctor, nurse or pharmacist if you have:
- hardening of the blood vessels
- Raynaud's disease, where the fingers become white and very painful when cold
- diabetes
- frostbite
- high blood pressure
- been treated with monoamine oxidase (MAO) inhibitors for depression
Interactions with this medication
As with most medicines, interactions with other drugs are possible. Tell your doctor, nurse, or pharmacist about all the medicines you take, including drugs prescribed by other doctors, vitamins, minerals, natural supplements, or alternative medicines.
The following may interact with Dopamine Hydrochloride and 5% Dextrose Injection, USP :
- some antidepressants (MAO inhibitors, tricyclic antidepressants)
- certain anesthetic agents used during surgery
- diuretic agents (“water pills”)
- some drugs used to treat high blood pressure and prevent the symptoms of angina (chest pain)
- some drugs used to treat psychiatric disorders
- drugs used to stop bleeding (such as ergonovine) and some oxytocic drugs (drugs used during labour)
- drugs used to control seizures, such as phenytoin
Proper use of this medication
Usual Dose
Your doctor will decide what dose you will receive. This depends on your condition and other factors, such as your weight.
Overdose
Dopamine Hydrochloride and 5% Dextrose Injection, USP is an intravenous (IV) drug given to you in hospital under the supervision of your doctor, so it is very unlikely that you will receive an overdose. An overdose could raise blood pressure too high.
In case of drug overdose, your doctor will reduce the amount or temporarily stop giving it to you. In some cases, your doctor may give you another drug to reduce your blood pressure.
Side effects and what to do about them
If you do not feel well while you are being given Dopamine Hydrochloride and 5% Dextrose Injection, USP or soon after the injection, tell your doctor, nurse or pharmacist as soon as possible.
Side effects may include:
- nausea
- vomiting
- headache
- anxiety
| Symptom / effect | Talk with your doctor, nurse, or pharmacist only if severe | Talk with your doctor, nurse, or pharmacist in all cases | Stop taking drug and talk with your doctor or pharmacist |
|---|---|---|---|
| Common | |||
| chest pain | ✔ | ||
| irregular or rapid heart beat | ✔ | ||
| low blood pressure / dizziness | ✔ | ||
| Uncommon | |||
| blood circulation problem / cold or tingling feet | ✔ | ||
| difficulty breathing | ✔ | ||
| Unknown | |||
| fever, irritation/in fection at the injection site; | ✔ | ||
| Venous Thrombosis (blood clot) or Phlebitis (inflammat ion of the vein): swelling, hard cordlike vein, redness, warmth and pain in the arm near the injection site; | ✔ | ||
| Allergic Reaction: rash, hives, swelling of the face, lips, tongue or throat, difficulty swallowing or breathing | ✔ | ||
This is not a complete list of side effects. For any unexpected effects after administration of Dopamine Hydrochloride and 5% Dextrose Injection, USP, speak with your doctor or pharmacist.
How to store
Dopamine Hydrochloride and 5% Dextrose Injection, USP is stored at room temperature (15-25°C), protected from light and freezing.
Reporting side effects
You can report any suspected adverse reactions associated with the use of health products to the Canada Vigilance Program by one of the following 3 ways:
- Report online at www.healthcanada.gc.ca/medeffect
- Call toll-free at 1-866-234-2345
- Complete a Canada Vigilance Reporting Form and:
- Fax toll-free to 1-866-678-6789, or
- Mail to:
Canada Vigilance Program
Health Canada
Postal Locator 0701E
Ottawa ON K1A 0K9
Postage paid labels, Canada Vigilance Reporting Form and the adverse reaction reporting guidelines are available on the MedEffectTM Canada Web site at www.healthcanada.gc.ca/medeffect.
NOTE: Should you require information related to the management of side effects, contact your health professional. The Canada Vigilance Program does not provide medical advice.
More information
This document plus the full product monograph, prepared for
health professionals can be obtained by contacting the sponsor,
Baxter Corporation at:
1-800-387-8399
This leaflet was prepared by Baxter Corporation.
Last revised: April 24, 2013.